Cargando…
The Role Of Circulating Tumor DNA In Therapeutic Resistance
The application of precision medicine in cancer treatment has partly succeeded in reducing the side effects of unnecessary chemotherapeutics and in improving the survival rate of patients. However, with the long-term use of therapy, the dynamically changing intratumoral and intertumoral heterogeneit...
Autores principales: | Xu, Chenxin, Cao, Haixia, Shi, Chen, Feng, Jifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850686/ https://www.ncbi.nlm.nih.gov/pubmed/31807023 http://dx.doi.org/10.2147/OTT.S226202 |
Ejemplares similares
-
The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis
por: Zhang, Lei, et al.
Publicado: (2019) -
CDCA4 suppresses epithelial–mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy
por: Xu, Chenxin, et al.
Publicado: (2021) -
Circulating tumor DNA detection: A potential tool for colorectal cancer management
por: Li, Huizi, et al.
Publicado: (2019) -
Tumor-derived exosomes in cancer progression and treatment failure
por: Yu, Shaorong, et al.
Publicado: (2015) -
Role of Circulating Tumor DNA in Hematological Malignancy
por: Ogawa, Miho, et al.
Publicado: (2021)